More Access and Evidence Articles

Access and Evidence

Value-Based Contracting: Do We Have The Data?

Andrew Stone, (Nov 20, 2018)

Deals have been signed. Promises have been made. But are companies delivering the goods?
Access and Evidence

How To Illustrate Your RWE To Payers

Adam Chapman, (Nov 1, 2018)

Data visualization tools are demystifying real-world evidence.
Access and Evidence

American Healthcare System 1 - 0 Europe

Andrew Stone, (Oct 23, 2018)

When it comes to pricing and access, the European healthcare system is losing.
Access and Evidence

Working with HTAs: It’s Your Move

Ross Davies, (Oct 16, 2018)

European HTA bodies have signaled that they want greater and earlier dialogue with pharma but is their call being answered?
Access and Evidence

Value: A Balancing Act

Ross Davies, (Oct 16, 2018)

When it comes to proving the value of a new medicine, pharma has to strike the right balance
Access and Evidence

Can Payers Trust Our Data?

Andrew Stone, (Oct 16, 2018)

Analyses from RWD are playing an increasingly important role, but will payers accept pharma’s figures?
Access and Evidence

Diving for Data

Andrew Stone, (Oct 16, 2018)

Finding the right data to underpin outcome-based contracts is not as easy as it looks
Access and Evidence

Rid Yourself Of Dirty Data

Andrew Stone, (Oct 11, 2018)

Real-world data holds enormous potential. But it also risks being riddled with bias.
Access and Evidence

Could Digital Medicines Improve Access For All?

Danielle Barron, (Sep 4, 2018)

Digital medicines could provide a new roadmap to reimbursement and regulatory approval.
Access and Evidence

Talking The Same Language

Adam Chapman, (Aug 10, 2018)

A universal standard for real-world evidence no longer seems quixotic. But how are companies going to do it?

Pages